Kyverna Therapeutics to Report Topline Results from Registrational Phase 2 KYSA-8 Trial of KYV-101 in Stiff Person Syndrome
– Company to host live webcast and conference call Monday, December 15,…
PDF Solutions to Make Its Analyst Day Webcast and Presentation Available
Company Also Reaffirms 2025 Financial Outlook December 01, 2025 19:01 ET  |…
Bright Minds Biosciences toPresent at Upcoming Conferences
October 30, 2025 18:30 ET Â | Source: Bright Minds Biosciences NEW YORK,…
authID to Report Third Quarter 2025 Financial Results on November 12, 2025
DENVER, Oct. 29, 2025 (GLOBE NEWSWIRE) -- authID® (Nasdaq: AUID) (“authID” or…
NTG Nordic Transport Group A/S – Q3 2025 Conference Call
October 10, 2025 04:00 ET Â | Source: NTG Nordic Transport Group A/S…
Immuneering to Discuss Recently Announced Overall Survival Data from Phase 2a Clinical Trial of Atebimetinib + mGnP in First-Line Pancreatic Cancer Patients on Monday, September 29, 2025
NEW YORK, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX),…
Upstream Bio to Host Conference Call and Webcast to Report Top-Line Data from the Phase 2 VIBRANT Trial of Verekitug in Patients with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
WALTHAM, Mass., Sept. 01, 2025 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq:…
Cytokinetics Announces Primary Results from MAPLE-HCM Presented at the European Society of Cardiology Congress 2025 and Published in The New England Journal Of Medicine
Positive Trial Demonstrates Superiority of Aficamten to Standard-of-Care Beta-Blocker Metoprolol Primary Endpoint…
SAP Executives to Participate in Upcoming Investor Events in Q3 2025
WALLDORF, Germany, Aug. 26, 2025 /PRNewswire/ -- SAP SE (NYSE: SAP) today…
Zelluna ASA Reports Second Quarter 2025 Financial Results and Provides General Business Update
Oslo, Norway, 20 August 2025 – Zelluna (OSE: ZLNA), a company pioneering…